A Phase 1 Trial of PD0332991 and Paclitaxel in Patients With Rb-Expressing Advanced Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2018
At a glance
- Drugs Palbociclib (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions
- 18 Jul 2016 Status changed from completed to active, no longer recruiting.
- 12 Dec 2015 Results presented at the 38th Annual San Antonio Breast Cancer Symposium
- 05 Jun 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov record.